Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other …
Over the last 12 months, insiders at Dyadic International, Inc. have bought $0 and sold $0 worth of Dyadic International, Inc. stock.
On average, over the past 5 years, insiders at Dyadic International, Inc. have bought $100,266 and sold $619,401 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,670 shares for transaction amount of $16,812 was made by Rawson Ping Wang (Chief Financial Officer) on 2021‑06‑03.
2022-07-07 | Sale | VP of Research and Bus. Dvlpmt | 1,089 0.0038% | $3.41 | $3,713 | -45.59% | ||
2021-12-23 | Sale | President and CEO | 28,767 0.1022% | $4.10 | $117,945 | -35.64% | ||
2021-12-22 | Sale | President and CEO | 35,649 0.1276% | $4.12 | $146,874 | -35.37% | ||
2021-12-21 | Sale | President and CEO | 26,486 0.0937% | $4.33 | $114,684 | -39.22% | ||
2021-06-09 | Sale | President and CEO | 23,000 0.0839% | $3.72 | $85,560 | +1.08% | ||
2021-06-08 | Sale | President and CEO | 30,000 0.1074% | $3.82 | $114,600 | -3.37% | ||
2021-06-07 | Sale | President and CEO | 44,000 0.1604% | $3.95 | $173,800 | -4.59% | ||
2021-06-04 | Sale | President and CEO | 132,000 0.48% | $3.85 | $508,200 | -2.22% | ||
2021-06-03 | Sale | President and CEO | 26,721 0.0969% | $3.61 | $96,463 | +4.17% | ||
2021-06-03 | Chief Financial Officer | 4,670 0.0169% | $3.60 | $16,812 | +4.17% | |||
2021-06-02 | Sale | President and CEO | 76,349 0.2814% | $3.74 | $285,545 | +2.18% | ||
2021-06-02 | Chief Financial Officer | 22,330 0.0823% | $3.74 | $83,454 | +2.18% | |||
2019-12-11 | Sale | VP of Research and Bus. Dvlpmt | 4,575 0.0167% | $5.80 | $26,535 | +8.48% | ||
2019-12-10 | Sale | VP of Research and Bus. Dvlpmt | 5,425 0.0201% | $5.84 | $31,682 | +9.23% | ||
2019-12-03 | Sale | director | 15,000 0.0546% | $6.18 | $92,700 | +1.13% | ||
2019-11-11 | Sale | VP of Research and Bus. Dvlpmt | 10,000 0.0366% | $5.99 | $59,900 | +3.69% | ||
2019-10-11 | Sale | VP of Research and Bus. Dvlpmt | 10,436 0.0356% | $6.08 | $63,451 | -6.00% | ||
2019-10-10 | Sale | VP of Research and Bus. Dvlpmt | 9,564 0.0219% | $3.73 | $35,626 | +3.12% | ||
2019-09-10 | Sale | VP of Research and Bus. Dvlpmt | 20,000 0.0463% | $3.34 | $66,800 | +14.12% | ||
2019-08-13 | Sale | VP of Research and Bus. Dvlpmt | 12,600 0.0437% | $5.75 | $72,450 | -1.31% |
KITT BARRY M | 10 percent owner | 1959172 6.6463% | $1.03 | 12 | 0 | |
Rawson Ping Wang | Chief Financial Officer | 35850 0.1216% | $1.03 | 2 | 0 | +3.17% |
Bandera Partners LLC | $2.62M | 5.36 | 1.57M | 0% | +$0 | 1.15 | |
Chapin Davis Inc | $1.38M | 2.83 | 826,301 | 0% | +$0 | 0.51 | |
The Vanguard Group | $1.34M | 2.75 | 804,038 | +0.01% | +$202.07 | <0.0001 | |
NORTHEAST FINANCIAL CONSULTANTS, INC | $417,500.00 | 0.86 | 250,000 | 0% | +$0 | 0.02 | |
BlackRock | $413,262.00 | 0.85 | 247,462 | -0.46% | -$1,923.84 | <0.0001 |